Literature DB >> 15542708

Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.

Yossef Itzhak1, Karen L Anderson, Syed F Ali.   

Abstract

It has been shown that mice deficient in neuronal nitric oxide synthase (nNOS) gene are resistant to cocaine-induced psychomotor sensitization and methamphetamine (METH)-induced dopaminergic neurotoxicity. The present study was undertaken to investigate the hypothesis that nNOS has a major role in dopamine (DA)- but not serotonin (5-hydroxytryptamine; 5-HT)-mediated effects of psychostimulants. The response of nNOS knockout (KO) and wild-type (WT) mice to the psychomotor-stimulating and neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy") and METH were investigated. Repeated administration of MDMA for 5 days resulted in psychomotor sensitization in both WT and nNOS KO mice, while repeated administration of METH caused psychomotor sensitization in WT but not in KO mice. Sensitization to both MDMA and METH was persistent for 40 days in WT mice, but not in nNOS KO mice. These findings suggest that the induction of psychomotor sensitization to MDMA and METH is NO independent and NO dependent, respectively, while the persistence of sensitization to both drugs is NO dependent. For the neurochemical studies, a high dose of MDMA caused marked depletion of 5-HT in several brain regions of both WT and KO mice, suggesting that the absence of the nNOS gene did not afford protection against MDMA-induced depletion of 5-HT. Striatal dopaminergic neurotoxicity caused by high doses of MDMA and METH in WT mice was partially prevented in KO mice administered with MDMA, but it was fully precluded in KO mice administered with METH. The differential response of nNOS KO mice to the behavioral and neurotoxic effects of MDMA and METH suggests that the nNOS gene is required for the expression and persistence of DA-mediated effects of METH and MDMA, while 5-HT-mediated effects of MDMA (induction of sensitization and 5-HT depletion) are not dependent on nNOS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542708     DOI: 10.1196/annals.1316.015

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity.

Authors:  Giulia Costa; Micaela Morelli; Nicola Simola
Journal:  Neurotox Res       Date:  2018-04-09       Impact factor: 3.911

2.  Inhibition of neuronal nitric oxide synthase prevents alterations in medial prefrontal cortex excitability induced by repeated cocaine administration.

Authors:  Fernando J Nasif; Xiu-Ti Hu; Oscar A Ramirez; Mariela F Perez
Journal:  Psychopharmacology (Berl)       Date:  2010-12-02       Impact factor: 4.530

3.  Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity.

Authors:  Elena Puerta; Isabel Hervias; Beatriz Goñi-Allo; Steven F Zhang; Joaquín Jordán; Anatoly A Starkov; Norberto Aguirre
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

4.  Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.

Authors:  Danielle M Friend; Jong H Son; Kristen A Keefe; Ashley N Fricks-Gleason
Journal:  J Pharmacol Exp Ther       Date:  2012-12-10       Impact factor: 4.030

Review 5.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

6.  Chronic wheel running reduces maladaptive patterns of methamphetamine intake: regulation by attenuation of methamphetamine-induced neuronal nitric oxide synthase.

Authors:  Alexander J Engelmann; Mark B Aparicio; Airee Kim; Jeffery C Sobieraj; Clara J Yuan; Yanabel Grant; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2013-02-27       Impact factor: 3.270

7.  In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.

Authors:  William E Fantegrossi; Brenda M Gannon; Sarah M Zimmerman; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2012-11-08       Impact factor: 7.853

Review 8.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

9.  Evaluating the role of neuronal nitric oxide synthase-containing striatal interneurons in methamphetamine-induced dopamine neurotoxicity.

Authors:  Ashley N Fricks-Gleason; Kristen A Keefe
Journal:  Neurotox Res       Date:  2013-04-11       Impact factor: 3.911

Review 10.  Evaluating Exercise as a Therapeutic Intervention for Methamphetamine Addiction-Like Behavior.

Authors:  Sucharita S Somkuwar; Miranda C Staples; McKenzie J Fannon; Atoosa Ghofranian; Chitra D Mandyam
Journal:  Brain Plast       Date:  2015-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.